A Comparative Study: The Use of Collagen Implant versus Mitomycin-C in Combined Trabeculotomy and Trabeculectomy for Treatment of Primary Congenital GlaucomaReportar como inadecuado




A Comparative Study: The Use of Collagen Implant versus Mitomycin-C in Combined Trabeculotomy and Trabeculectomy for Treatment of Primary Congenital Glaucoma - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Journal of Ophthalmology - Volume 2017 2017, Article ID 9241459, 7 pages - https:-doi.org-10.1155-2017-9241459

Clinical StudyOphthalmology Department, Sohag University, Sohag, Egypt

Correspondence should be addressed to Mohammed Iqbal Hafez Saleem

Received 6 November 2016; Revised 15 February 2017; Accepted 13 March 2017; Published 23 April 2017

Academic Editor: Antonio M. Fea

Copyright © 2017 Alaa Abdel Sadek Singab et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose. To compare Ologen implant versus mitomycin-C MMC in combined trabeculotomy and trabeculectomy as a treatment of primary congenital glaucoma. Setting. Sohag University Hospital, Egypt. Design. A prospective comparative study. Methods. Thirty-four eyes of twenty-one patients with primary congenital glaucoma were included in this study. All patients were subjected to preoperative evaluation including complete anterior segment examination under general anesthesia. The patients were divided into two groups: patients of the first group group A underwent combined trabeculotomy and trabeculectomy with Ologen implantation while those of the second group group B underwent combined trabeculotomy and trabeculectomy with MMC application. Results. Postoperatively, the IOP in group A was as follows: 8 eyes developed IOP levels less than 14 mmHg complete success, 3 eyes had levels between 14 and 16 mmHg accepted result, 2 eyes had levels between 16 and 20 mmHg guarded result, and only 2 eyes showed levels exceeding 20 mmHg failed procedure, while in group B, 7 eyes showed complete success, 3 eyes had accepted result, 3 eyes had guarded result, and 2 eyes had failed procedure. Conclusion. Ologen is a safe and effective adjuvant in combined trabeculotomy and trabeculectomy for treatment of primary congenital glaucoma.





Autor: Alaa Abdel Sadek Singab, Osama Ali Mohammed, Mohammed Iqbal Hafez Saleem, and Mortada Ahmed Abozaid

Fuente: https://www.hindawi.com/



DESCARGAR PDF




Documentos relacionados